Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nicholson-Weller

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|August 1, 1988
Complement induces a transient increase in membrane permeability in unlysed erythrocytesJ A Halperin, A Nicholson-Weller, C Brugnara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1986
Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9M L Shin, G Hänsch, V W Hu, et al.
Immunology Letters|April 1, 1987
Decay accelerating factor (DAF) peptide sequences share homology with a consensus sequence found in the superfamily of structurally related complement proteins and other proteins including haptoglobin, factor XIII, beta 2-glycoprotein I, and the IL-2 receptorA Nicholson-Weller, J Zaia, M G Raum, et al.
Journal of Molecular Evolution|August 12, 1999
Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9M Mondragón-Palomino, D Piñero, A Nicholson-Weller, et al.
The Journal of Biological Chemistry|September 25, 1989
Factor J: isolation and characterization of a new polypeptide inhibitor of complement C1M Lopez-Trascasa, D H Bing, M Rivard, et al.
The Journal of Experimental Medicine|May 1, 1980
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusM S Edwards, A Nicholson-Weller, C J Baker, et al.
The Journal of Infectious Diseases|June 1, 1984
Potentiation of virulence by group B streptococcal polysaccharidesN J Levy, A Nicholson-Weller, C J Baker, et al.
The American Journal of Pathology|November 1, 1989
Cytoplasmic lipid bodies of human neutrophilic leukocytesP F Weller, S J Ackerman, A Nicholson-Weller, et al.
The Journal of Experimental Medicine|January 1, 1989
Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120D R Lucey, D I Dorsky, A Nicholson-Weller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesionS W Tas, L B Klickstein, S F Barbashov, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|August 1, 1988
Complement induces a transient increase in membrane permeability in unlysed erythrocytesJ A Halperin, A Nicholson-Weller, C Brugnara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1986
Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9M L Shin, G Hänsch, V W Hu, et al.
Immunology Letters|April 1, 1987
Decay accelerating factor (DAF) peptide sequences share homology with a consensus sequence found in the superfamily of structurally related complement proteins and other proteins including haptoglobin, factor XIII, beta 2-glycoprotein I, and the IL-2 receptorA Nicholson-Weller, J Zaia, M G Raum, et al.
Journal of Molecular Evolution|August 12, 1999
Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9M Mondragón-Palomino, D Piñero, A Nicholson-Weller, et al.
The Journal of Biological Chemistry|September 25, 1989
Factor J: isolation and characterization of a new polypeptide inhibitor of complement C1M Lopez-Trascasa, D H Bing, M Rivard, et al.
The Journal of Experimental Medicine|May 1, 1980
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B StreptococcusM S Edwards, A Nicholson-Weller, C J Baker, et al.
The Journal of Infectious Diseases|June 1, 1984
Potentiation of virulence by group B streptococcal polysaccharidesN J Levy, A Nicholson-Weller, C J Baker, et al.
The American Journal of Pathology|November 1, 1989
Cytoplasmic lipid bodies of human neutrophilic leukocytesP F Weller, S J Ackerman, A Nicholson-Weller, et al.
The Journal of Experimental Medicine|January 1, 1989
Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120D R Lucey, D I Dorsky, A Nicholson-Weller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesionS W Tas, L B Klickstein, S F Barbashov, et al.
Pageof 7